296 results on '"Horiguchi, Norio"'
Search Results
2. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients
3. Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin
4. Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C
5. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery
6. Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation
7. Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation
8. Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR
9. Adolescents with chronic hepatitis C might be good candidates for direct‐acting antiviral therapy
10. # 1439 Three cases of the hepatitis C patients that presented hyperkalemia during daclatasvir and asunaprevir combination therapy
11. # 1018 Hepatic angiosarcoma with dyskeratosis congenita
12. # 1093 Malignant peripheral nerve sheath tumor of the liver
13. # 1011 A case of endoscopic treatment for esophageal varices complicated by Isaacsʼ syndrome involving difficulty with conventional sedation
14. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma
15. A case of hemorrhagic gastroduodenitis after proton beam radiation for pancreatic cancer with multiple hemorrhagic risk factors: successful treatment with argon plasma coagulation
16. Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis
17. Paracrine Activation of Hepatic CB 1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
18. HGF ameliorates a high-fat diet-induced fatty liver
19. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis
20. Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation
21. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis
22. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine
23. Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads
24. Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin
25. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10–deficient mice
26. Reply
27. Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines
28. Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1
29. Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis
30. Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
31. Dissociation Between Liver Inflammation and Hepatocellular Damage Induced by Carbon Tetrachloride in Myeloid Cell–Specific Signal Transducer and Activator of Transcription 3 Gene Knockout Mice
32. Anti-Inflammatory and Anti-Apoptotic Roles of Endothelial Cell STAT3 in Alcoholic Liver Injury
33. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice
34. Transforming growth factor-α accelerates hepatocyte repopulation after hepatocyte transplantation
35. Elevated plasma resistin concentrations in patients with liver cirrhosis
36. ROLE OF STAT 3 IN ALCOHOLIC FATTY LIVER: 243
37. CHRONIC ETHANOL CONSUMPTION INHIBITS HEPATIC NK CELL ACTIVITY BY ATTENUATION OF ACTIVATING SIGNAL AND ACCELERATES MCMV-INDUCED HEPATITIS: 833
38. ANTI-STEATOTIC EFFECT OF STAT3 IN ALCOHOLIC FATTY LIVER DISEASE VIA SUPPRESSION OF SREBP-1: 097
39. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice
40. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury
41. Role of serum soluble Fas/soluble Fas ligand and TNF-α on response to interferon-α therapy in chronic hepatitis C
42. Iron enhances hepatitis C virus replication in cultured human hepatocytes
43. Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
44. Mo1463 – Drug Induced Liver Injury Due to Immune Checkpoint Blockades in Japan
45. Su1561 – Long-Term Results of Bariatric Surgery for Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients
46. Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology
47. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients
48. Integrative roles of transforming growth factor-α in the cytoprotection mechanisms of gastric mucosal injury
49. A patient with type I Gaucher disease who switched from enzyme replacement therapy to substrate reduction therapy after having of CYP2D6 polymorphisms checked
50. Su1488 - Dissecting the Role of Macrophage Inhibitory Factor (MIF) on Murine NAFLD/NASH Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.